ATE451393T1 - Humane anti-idiotypische antikörperfragmente, die her-2/neu ähneln - Google Patents

Humane anti-idiotypische antikörperfragmente, die her-2/neu ähneln

Info

Publication number
ATE451393T1
ATE451393T1 AT04806335T AT04806335T ATE451393T1 AT E451393 T1 ATE451393 T1 AT E451393T1 AT 04806335 T AT04806335 T AT 04806335T AT 04806335 T AT04806335 T AT 04806335T AT E451393 T1 ATE451393 T1 AT E451393T1
Authority
AT
Austria
Prior art keywords
antibody fragments
human anti
new
idiotypic antibody
fragments similar
Prior art date
Application number
AT04806335T
Other languages
English (en)
Inventor
Philippe Gauthier
Andre Pelegrin
Mickael Coelho
Isabelle Teulon
Original Assignee
Inst Nat Sante Rech Med
Ct Regional De Lutte Contre Le
Univ Montpellier I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Ct Regional De Lutte Contre Le, Univ Montpellier I filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE451393T1 publication Critical patent/ATE451393T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04806335T 2003-12-17 2004-12-14 Humane anti-idiotypische antikörperfragmente, die her-2/neu ähneln ATE451393T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03293196A EP1544215A1 (de) 2003-12-17 2003-12-17 Humane antiidiotypische Antikörperfragmente die HER-2/neu nachahmen
PCT/IB2004/004096 WO2005061546A1 (en) 2003-12-17 2004-12-14 Human anti-idiotypic antibody fragments that mimic her-2/neu

Publications (1)

Publication Number Publication Date
ATE451393T1 true ATE451393T1 (de) 2009-12-15

Family

ID=34486483

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04806335T ATE451393T1 (de) 2003-12-17 2004-12-14 Humane anti-idiotypische antikörperfragmente, die her-2/neu ähneln

Country Status (8)

Country Link
US (2) US7892542B2 (de)
EP (2) EP1544215A1 (de)
JP (1) JP4709161B2 (de)
AT (1) ATE451393T1 (de)
CA (1) CA2549937A1 (de)
DE (1) DE602004024574D1 (de)
ES (1) ES2335350T3 (de)
WO (1) WO2005061546A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1539235A2 (de) 2002-07-01 2005-06-15 Human Genome Sciences, Inc. Spezifisch an reg iv bindende antikörper
FR2879605B1 (fr) 2004-12-16 2008-10-17 Centre Nat Rech Scient Cnrse Production de formats d'anticorps et applications immunologiques de ces formats
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
CA2822302A1 (en) 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Methods of impairing osteoclast differentiation
US8501417B2 (en) 2007-06-26 2013-08-06 Vanderbilt University Immunological compositions as cancer biomarkers and/or therapeutics
WO2010130677A1 (en) * 2009-05-13 2010-11-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vhh antibody fragments that mimic her-2/neu
HK1210192A1 (en) 2012-07-19 2016-04-15 Alethia Biotherapeutics Inc. Anti-siglec-15 antibodies
WO2017149122A1 (en) * 2016-03-04 2017-09-08 Morphosys Ag Clinical assessment of m-protein response in multiple myeloma
WO2021050696A1 (en) * 2019-09-10 2021-03-18 The Research Foundation For The State University Of New York Compositions and methods for improving tumor penetration of tumor specific antibodies
AU2024277678A1 (en) * 2023-05-25 2025-11-27 Dispatch Biotherapeutics, Inc. Synthetic cancer antigens as targets for treating cancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637677A (en) * 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
US5560911A (en) * 1993-10-12 1996-10-01 Oklahoma Medical Research Foundation Method of inhibiting acute complement mediated cytotoxicity with anti-idiotypic antibodies

Also Published As

Publication number Publication date
US20070298033A1 (en) 2007-12-27
EP1544215A1 (de) 2005-06-22
EP1694707A1 (de) 2006-08-30
EP1694707B1 (de) 2009-12-09
JP2008504221A (ja) 2008-02-14
CA2549937A1 (en) 2005-07-07
WO2005061546A1 (en) 2005-07-07
US7892542B2 (en) 2011-02-22
US20110110929A1 (en) 2011-05-12
JP4709161B2 (ja) 2011-06-22
ES2335350T3 (es) 2010-03-25
DE602004024574D1 (de) 2010-01-21

Similar Documents

Publication Publication Date Title
CY1123535T1 (el) Υποκαταστατο θεραπευτικο τελικο σημειο για βασιζομενη σε anti-ctla-4 ανοσοθεραπεια ασθενειας
DK1565489T3 (da) Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet
SA519402358B1 (ar) Ccr7 مترافقات عقار جسم مضاد لـ
ATE509032T1 (de) Chimerizierte gm-csf antikörper
CY1119512T1 (el) Αντισωματα του υποδοχεα 1 της ιντερφερονης αλφα και οι χρησεις αυτων
CY1117090T1 (el) Χιμαιρικες πρωτεϊνες παραγοντα πηξης για την αγωγη αιμοστατικων ασθενειων
CY1114658T1 (el) Πρωτεϊνες δεσμευσης αντιγονου του αυξητικου παραγοντα τυπου επιδερμικου αυξητικου παραγοντα προσδεσης στην ηπαρινη
CY1111622T1 (el) Ανθρωποποιημενοι ανταγωνιστες anti-cmet
PL2097453T3 (pl) Przeciwciała monoklonalne przeciw ludzkiemu receptorowi hormonu anty-Mullerowskiego typu II (AMHR-II)
TW200510459A (en) RG1 antibodies and uses thereof
CY1116167T1 (el) Φαρμακευτικeς συνθεσεις κατευθυνομενες σε υποδοχεις erb-b1
WO2017004026A8 (en) Anti-cd123 antibodies and conjugates and derivatives thereof
WO2005062977A3 (en) Prostate cancer specific internalizing human antibodies
MY154009A (en) Anti-alpha v beta 6 antibodies
MX2009009926A (es) Anticuerpo tumor-especifico humano monoclonal.
WO2006084078A3 (en) Jam-3 and antibodies that bind thereto
DK1641828T3 (da) Anti-HGF-R-antistoffer og deres anvendelse
BRPI0414513A (pt) kid3 e anticorpos de kid3 que se ligam a ele
PT1557462E (pt) Células de indução da aceitação de um transplante de origem monocítica e a sua preparação e utilização
EA202191769A1 (ru) Тубулизины и конъюгаты белок-тубулизин
ATE526037T1 (de) Verfahren zum abtöten von tumorzellen mittels targeting von auf apoptotischen tumorzellen exponierten internen antigenen
ITTO20020340A1 (it) Localizzazione del recettore her2 mediante anticorpo umanizzato biotinilato.
ATE451393T1 (de) Humane anti-idiotypische antikörperfragmente, die her-2/neu ähneln
WO2004043239A3 (en) Antigen pipa and antibodies that bind thereto
WO2006083852A3 (en) Luca2 and antibodies that bind thereto

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties